A shadow market for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings.
Investigational Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts privately for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the substance there before directing buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in individuals administering products of unknown origin.
Some experts stated the popularity for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking fines, prosecution or imprisonment.
Platform Response and Content Removal
According to TikTok, the service has taken down problematic content and prohibited associated hashtags and query recommendations. The company stated it was committed to keeping the service safe and investing in enhancing compliance measures.
Online Trading Activities
Research also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of weight loss, glowing reviews and detailed guides for mixing or administering at residence.
Within minutes of joining one group, a vendor shared contact information, where the majority of transactions occur. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.
Product Information and Costs
Within these communities, posts show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Security Measures
A representative for the messaging service stated it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has already encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to possibly significant medical dangers”.
